Diagnosis and individual treatment of cardiovascular diseases: targeting vascular oxidative stress

Melanie E Armitage1, Mylinh La, Harald H H W Schmidt

  • 1Florey Neuroscience Institutes, National Stroke Research Institute, Heidelberg, Melbourne, VIC 3084, Australia.

Insights

New strategies for cardiovascular diseases focus on individualized medicine. Targeting oxidative stress sources, not just symptoms, offers a more effective and cost-saving approach to preventing and treating these conditions.

Area of Science:

  • Biomedical research
  • Cardiovascular medicine
  • Oxidative stress

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality and morbidity.
  • Current CVD treatments are often symptom-oriented and lack personalization.
  • A deeper understanding of CVDs' underlying mechanisms is crucial for effective prevention and treatment.

Purpose of the Study:

  • To explore the role of oxidative stress in cardiovascular disease pathogenesis.
  • To propose novel therapeutic strategies beyond traditional antioxidant supplements.
  • To highlight the potential of individualized medicine in managing CVDs.

Main Methods:

  • Reviewing the limitations of current antioxidant supplement approaches for CVDs.
  • Investigating oxidative stress as a key mechanism in endothelial dysfunction.
  • Identifying enzymatic sources of reactive oxygen species in the vascular wall.
  • Exploring emerging biomarkers for oxidative stress in CVDs.

Main Results:

  • Traditional antioxidant supplements have proven ineffective for CVDs.
  • Oxidative stress, driven by reactive oxygen species, contributes to endothelial dysfunction.
  • Targeting enzymatic sources of oxidative stress presents a promising alternative.
  • Emerging biomarkers can aid in monitoring oxidative stress levels.

Conclusions:

  • Individualized medicine, incorporating diagnostics, molecular imaging, and mechanism-based drugs, is essential for advancing CVD care.
  • Targeting the enzymatic origins of oxidative stress offers a more effective strategy than general antioxidant supplementation.
  • This approach promises more individualized, effective, and cost-efficient CVD management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...